Carboplatin-based adjuvant chemotherapy versus observation after radical cystectomy in patients with pN1-3 urothelial bladder cancer-Reference-Cited by-同舟云学术

Carboplatin-based adjuvant chemotherapy versus observation after radical cystectomy in patients with pN1-3 urothelial bladder cancer

Published:2022-02-10 Issue:6 Volume:40 Page:1489-1496
ISSN:1433-8726
Container-title:World Journal of Urology
language:en
Short-container-title:World J Urol

Author:

Afferi Luca^ORCID,Lonati Chiara,Montorsi Francesco,Briganti Alberto,Necchi Andrea,Mari Andrea,Minervini Andrea,Campi Riccardo,di Trapani Ettore,de Cobelli Ottavio,Karnes R. Jeffrey,Ahmed Mohamed,Mir M. Carmen,Algarra Maria Asuncion,Rink Michael,Zamboni Stefania,Simeone Claudio,Krajewski Wojciech,Xylinas Evanguelos,Soria Francesco,Hendricksen Kees,Einerhand Sarah,Mattei Agostino,Carando Roberto,Roumiguié Mathieu,Bajeot Anne Sophie,Black Peter C.,Shariat Shahrokh F.,Moschini Marco,

Publisher

Springer Science and Business Media LLC

Subject

Urology

Link

https://link.springer.com/content/pdf/10.1007/s00345-022-03948-x.pdf

Reference31 articles.

1. Witjes JA, Bruins HM, Cathomas R, Compérat EM, Cowan NC, Gakis G et al (2021) European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: summary of the 2020 Guidelines. Eur Urol 79(1):82–104

2. Russell B, Liedberg F, Khan MS, Nair R, Thurairaja R, Malde S et al (2020) A systematic review and meta-analysis of delay in radical cystectomy and the effect on survival in bladder cancer patients. Eur Urol Oncol 3(2):239–249

3. Nadal R, Apolo AB (2018) Overview of current and future adjuvant therapy for muscle-invasive urothelial carcinoma. Curr Treat Options Oncol 19(7):36

4. Dogan S, Hennig M, Frank T, Struck JP, Cebulla A, Salem J et al (2018) Acceptance of adjuvant and neoadjuvant chemotherapy in muscle-invasive bladder cancer in Germany: a survey of current practice. Urologia Int 101:25–30

5. Dash A, Galsky MD, Vickers AJ, Serio AM, Koppie TM, Dalbagni G et al (2006) Impact of renal impairment on eligibility for adjuvant cisplatin-based chemotherapy in patients with urothelial carcinoma of the bladder. Cancer 107(3):506–513

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effectiveness of adjuvant chemotherapy for patients who undergo radical cystectomy without neoadjuvant chemotherapy: A retrospective cohort study of 115 advanced bladder cancer patients with pathological lymph node classification;International Journal of Urology;2024-04-12

2. Patterns of Utilization and Outcomes of Perioperative Chemotherapy in Patients With Locally Advanced-urothelial Bladder Cancer (LABC)-Real World Data From an Indian Tertiary Care Cancer Center;Clinical Genitourinary Cancer;2023-10

3. Carboplatin Induction Chemotherapy in Clinically Lymph Node–positive Bladder Cancer;European Urology Open Science;2023-05

4. Evolving systemic management of urothelial cancers;Current Opinion in Oncology;2023-03-14